Stay updated on XMT-1660 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.

Latest updates to the XMT-1660 in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s footer revision indicator was updated from “v3.5.2” to “v3.5.3,” indicating a system/version update with no change to the displayed study details.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded UCLA David Geffen School of Medicine, Division of Hematology/Oncology and Sarah Cannon Research Institute (SCRI) with investigator Jennifer Specht, MD. Removed UCLA and Tennessee Oncology, PLLC and Natasha Hunter, MD.SummaryDifference0.3%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details page.SummaryDifference0.0%

- Check64 days agoChange Detected- Revision: v3.4.3 added.\n- Revision: v3.4.2 removed.\n- No changes to study data or page content.SummaryDifference0.0%

- Check86 days agoChange DetectedFallopian Tube Cancer has been added to the study's listed conditions. The page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check93 days agoChange DetectedA minor revision label on the page updated from v3.4.0 to v3.4.1; no trial information changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to XMT-1660 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.